Familial cancer syndromes and clusters

Area of Science:

• Oncology
• Human Genetics
• Molecular Biology

Background:

• Familial cancer aggregation is common, with relatives of cancer patients having a 2-3 fold increased risk.
• Excess risk in cancer families is heterogeneous, ranging up to 1000-fold, influenced by inherited susceptibility, environmental factors, and chance.
• Distinguishing true predisposition from chance requires specialized studies due to the high lifetime cancer risk in the general population.

Purpose of the Study:

• To explore the role of inherited susceptibility in familial cancer aggregation.
• To highlight the importance of molecular biology in understanding cancer predisposition.
• To discuss the clinical applications of identifying cancer families.

Main Methods:

• Review of existing literature on familial cancer aggregation and hereditary cancer syndromes.
• Application of molecular probes to map human cancer gene loci.
• Identification and characterization of tumor suppressor genes, including the retinoblastoma gene.

Main Results:

• Inherited susceptibility often manifests as earlier onset, bilateral occurrence, multiple primary foci, or tumors in organs with shared embryological origins.
• Molecular studies have identified cancer gene loci and revealed tumor suppressor genes crucial for cancer development.
• The retinoblastoma gene serves as a key example of a tumor suppressor involved in numerous cancers.

Conclusions:

• Familial cancer clusters can be attributed to inherited susceptibility, environmental factors, or chance, necessitating careful evaluation.
• Advances in molecular biology, particularly the study of tumor suppressor genes, have significantly advanced the understanding of hereditary cancer.
• Identifying cancer families is crucial for genetic counseling, in-utero diagnosis, and early detection, while patient education can mitigate environmentally triggered cancers.